These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 11344192

  • 1. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
    Frénais R, Nazih H, Ouguerram K, Maugeais C, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M.
    J Clin Endocrinol Metab; 2001 May; 86(5):1962-7. PubMed ID: 11344192
    [Abstract] [Full Text] [Related]

  • 2. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O, Duhal N, Lacroix B, Bonte JP, Fruchart JC, Luc G.
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
    Goldberg IJ, Blaner WS, Vanni TM, Moukides M, Ramakrishnan R.
    J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC, Shiu SW, Pang RW, Kung AW.
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
    Brinton EA, Eisenberg S, Breslow JL.
    J Clin Invest; 1991 Feb; 87(2):536-44. PubMed ID: 1899429
    [Abstract] [Full Text] [Related]

  • 10. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
    Pietzsch J, Julius U, Nitzsche S, Hanefeld M.
    Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J, Nakajima K, Nohara A, Kawashiri M, Yagi K, Inazu A, Koizumi J, Yamagishi M, Mabuchi H.
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
    Briand F, Magot T, Krempf M, Nguyen P, Ouguerram K.
    Eur J Clin Invest; 2006 Apr; 36(4):224-30. PubMed ID: 16620283
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.